ANIP
Price
$63.93
Change
+$0.58 (+0.92%)
Updated
Aug 1 closing price
Capitalization
1.43B
4 days until earnings call
RGC
Price
$12.97
Change
-$1.46 (-10.12%)
Updated
Aug 1 closing price
Capitalization
50.75M
Interact to see
Advertisement

ANIP vs RGC

Header iconANIP vs RGC Comparison
Open Charts ANIP vs RGCBanner chart's image
ANI Pharmaceuticals
Price$63.93
Change+$0.58 (+0.92%)
Volume$318.82K
Capitalization1.43B
Regencell Bioscience Holdings
Price$12.97
Change-$1.46 (-10.12%)
Volume$369.42K
Capitalization50.75M
ANIP vs RGC Comparison Chart in %
Loading...
ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANIP vs. RGC commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIP is a StrongBuy and RGC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 02, 2025
Stock price -- (ANIP: $63.93 vs. RGC: $13.20)
Brand notoriety: ANIP and RGC are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ANIP: 109% vs. RGC: 18%
Market capitalization -- ANIP: $1.43B vs. RGC: $50.75M
ANIP [@Pharmaceuticals: Other] is valued at $1.43B. RGC’s [@Pharmaceuticals: Other] market capitalization is $50.75M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIP’s FA Score shows that 0 FA rating(s) are green whileRGC’s FA Score has 0 green FA rating(s).

  • ANIP’s FA Score: 0 green, 5 red.
  • RGC’s FA Score: 0 green, 5 red.
According to our system of comparison, ANIP is a better buy in the long-term than RGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIP’s TA Score shows that 3 TA indicator(s) are bullish while RGC’s TA Score has 3 bullish TA indicator(s).

  • ANIP’s TA Score: 3 bullish, 5 bearish.
  • RGC’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, RGC is a better buy in the short-term than ANIP.

Price Growth

ANIP (@Pharmaceuticals: Other) experienced а -5.26% price change this week, while RGC (@Pharmaceuticals: Other) price change was -13.04% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.01%. For the same industry, the average monthly price growth was +5.21%, and the average quarterly price growth was +81.83%.

Reported Earning Dates

ANIP is expected to report earnings on Nov 05, 2025.

RGC is expected to report earnings on Jun 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-2.01% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANIP($1.43B) has a higher market cap than RGC($50.8M). RGC YTD gains are higher at: 9876.844 vs. ANIP (15.648). ANIP has higher annual earnings (EBITDA): 107M vs. RGC (-4.67M). ANIP has more cash in the bank: 221M vs. RGC (306K). RGC has less debt than ANIP: RGC (3.54M) vs ANIP (286M). ANIP has higher revenues than RGC: ANIP (487M) vs RGC (0).
ANIPRGCANIP / RGC
Capitalization1.43B50.8M2,815%
EBITDA107M-4.67M-2,290%
Gain YTD15.6489876.8440%
P/E Ratio79.85N/A-
Revenue487M0-
Total Cash221M306K72,222%
Total Debt286M3.54M8,072%
FUNDAMENTALS RATINGS
ANIP vs RGC: Fundamental Ratings
ANIP
RGC
OUTLOOK RATING
1..100
6786
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
44100
SMR RATING
1..100
90100
PRICE GROWTH RATING
1..100
5934
P/E GROWTH RATING
1..100
92100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ANIP's Valuation (93) in the Pharmaceuticals Other industry is in the same range as RGC (95) in the Movies Or Entertainment industry. This means that ANIP’s stock grew similarly to RGC’s over the last 12 months.

ANIP's Profit vs Risk Rating (44) in the Pharmaceuticals Other industry is somewhat better than the same rating for RGC (100) in the Movies Or Entertainment industry. This means that ANIP’s stock grew somewhat faster than RGC’s over the last 12 months.

ANIP's SMR Rating (90) in the Pharmaceuticals Other industry is in the same range as RGC (100) in the Movies Or Entertainment industry. This means that ANIP’s stock grew similarly to RGC’s over the last 12 months.

RGC's Price Growth Rating (34) in the Movies Or Entertainment industry is in the same range as ANIP (59) in the Pharmaceuticals Other industry. This means that RGC’s stock grew similarly to ANIP’s over the last 12 months.

ANIP's P/E Growth Rating (92) in the Pharmaceuticals Other industry is in the same range as RGC (100) in the Movies Or Entertainment industry. This means that ANIP’s stock grew similarly to RGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIPRGC
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 10 days ago
74%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
72%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UTZ13.640.61
+4.68%
Utz Brands
ABEO6.490.12
+1.88%
Abeona Therapeutics
REMYF59.70-1.61
-2.63%
Remy Cointreau SA
LOAR71.40-2.51
-3.40%
Loar Holdings
MGLD0.82-0.06
-6.65%
Marygold Companies (The)

RGC and

Correlation & Price change

A.I.dvisor tells us that RGC and QNTM have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RGC and QNTM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGC
1D Price
Change %
RGC100%
-10.12%
QNTM - RGC
21%
Poorly correlated
+0.98%
SBFM - RGC
20%
Poorly correlated
-2.08%
ANIP - RGC
11%
Poorly correlated
+0.92%
PCRX - RGC
11%
Poorly correlated
+4.65%
CPIX - RGC
8%
Poorly correlated
+2.03%
More